StratMum(TM) Technology for Injectable Delivery
Products
Information
The StratMum(TM) technology, for injectable delivery, allows for precise control of particle size and composition enabling predictable injectable performance, which is critical for self-administration, extended release, and modified release applications with a narrow therapeutic index. Unlike other encapsulation techniques, Strat?m(R) is capable of producing single- or double-layer particles in a one manufacturing step, lending to creation of next-generation pulsatile release formulations or extended release formulations. This technology is ideal for injectable small molecules, proteins, peptides, vaccines, and heat-labile molecules and requires lyophilization.
Available In
North America (USA, Canada)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
United States
Categories
Contract ManufacturingContract Services - Contract ServicesFormulation developmentPharmaceutical Machinery & TechnologyControlled, customized or modified drug release
